Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The biological functions of the BCL2 gene were investigated in transgenic mice harboring human BCL2 cDNA under the control of an immunoglobulin heavy chain enhancer (E mu). Mice of a representative transgenic strain, E mu-bcl-2-22, had a great excess of B lymphocytes, immunoglobulin-secreting cells, and serum immunoglobulins, attributable to increased longevity of B-lineage cells. Pre-B and plasma cells as well as B cells exhibited prolonged survival in culture. Immunized animals produced an amplified and protracted antibody response. Within the first year of life, most mice spontaneously produced antibodies to nuclear antigens, and 60% developed kidney disease, diagnosed as immune complex glomerulonephritis. Thus E mu-bcl-2-22 mice constitute a transgenic model for a systemic autoimmune disease resembling the human disorder systemic lupus erythematosus.

Type

Journal article

Journal

Proc Natl Acad Sci U S A

Publication Date

01/10/1991

Volume

88

Pages

8661 - 8665

Keywords

Animals, Antibody Formation, Antibody-Producing Cells, Autoimmune Diseases, B-Lymphocytes, Cell Survival, Female, Gene Expression, Humans, Male, Mice, Mice, Transgenic, Plasma Cells, Proto-Oncogene Proteins, Proto-Oncogene Proteins c-bcl-2, Proto-Oncogenes, Time Factors